Catalytic C–H functionalization using metal carbenoids and nitrenoids has emerged as a powerful strategy in organic synthesis, offering new approaches for the selective modification of carbon–hydrogen bonds. This method involves the insertion of metal carbenes or nitrenes into C–H bonds, enabling the formation of complex molecules with high regio- and stereoselectivity. The approach has been particularly useful in the synthesis of pharmaceutical agents and natural products, where traditional methods often require complex multi-step processes. The use of metal carbenoids, generated by the decomposition of diazo compounds, allows for the activation of C–H bonds, leading to efficient and selective transformations. Chiral catalysts have been instrumental in achieving enantioselectivity, as demonstrated in the synthesis of compounds such as baclofen and rolipram. The development of donor/acceptor functionalized carbenoids has further enhanced the selectivity and reactivity of these systems, enabling the synthesis of complex molecules with high efficiency. Similarly, metal nitrenoids have been shown to be effective in C–H amination reactions, which can be used to form nitrogen-containing compounds with high diastereoselectivity. These reactions have been applied in the synthesis of natural products such as manzacidin A and saxitoxin. The use of chiral catalysts in these reactions has allowed for the enantioselective synthesis of compounds like tetrodotoxin. The potential of C–H functionalization extends to the synthesis of complex natural products, where it offers a more direct and efficient approach compared to traditional methods. The combined C–H activation/Cope rearrangement has been particularly useful in the synthesis of compounds such as sertraline and tris-indole derivatives. The ability of these reactions to generate complex molecules with high stereocontrol highlights their importance in pharmaceutical and natural product synthesis. As research in this area continues, the development of more efficient and selective catalysts will further enhance the utility of C–H functionalization in the synthesis of pharmaceuticals and natural products. This methodology is expected to play a significant role in the future of organic synthesis, providing new strategies for the efficient and selective modification of carbon–hydrogen bonds.Catalytic C–H functionalization using metal carbenoids and nitrenoids has emerged as a powerful strategy in organic synthesis, offering new approaches for the selective modification of carbon–hydrogen bonds. This method involves the insertion of metal carbenes or nitrenes into C–H bonds, enabling the formation of complex molecules with high regio- and stereoselectivity. The approach has been particularly useful in the synthesis of pharmaceutical agents and natural products, where traditional methods often require complex multi-step processes. The use of metal carbenoids, generated by the decomposition of diazo compounds, allows for the activation of C–H bonds, leading to efficient and selective transformations. Chiral catalysts have been instrumental in achieving enantioselectivity, as demonstrated in the synthesis of compounds such as baclofen and rolipram. The development of donor/acceptor functionalized carbenoids has further enhanced the selectivity and reactivity of these systems, enabling the synthesis of complex molecules with high efficiency. Similarly, metal nitrenoids have been shown to be effective in C–H amination reactions, which can be used to form nitrogen-containing compounds with high diastereoselectivity. These reactions have been applied in the synthesis of natural products such as manzacidin A and saxitoxin. The use of chiral catalysts in these reactions has allowed for the enantioselective synthesis of compounds like tetrodotoxin. The potential of C–H functionalization extends to the synthesis of complex natural products, where it offers a more direct and efficient approach compared to traditional methods. The combined C–H activation/Cope rearrangement has been particularly useful in the synthesis of compounds such as sertraline and tris-indole derivatives. The ability of these reactions to generate complex molecules with high stereocontrol highlights their importance in pharmaceutical and natural product synthesis. As research in this area continues, the development of more efficient and selective catalysts will further enhance the utility of C–H functionalization in the synthesis of pharmaceuticals and natural products. This methodology is expected to play a significant role in the future of organic synthesis, providing new strategies for the efficient and selective modification of carbon–hydrogen bonds.